Talcum Powder Cancer Lawsuit

Limited Courtroom Attendees Will Hear Talcum Powder Cancer Appeal on April 24

More cases against Johnson & Johnson and others may make it to court in May as restrictions over COVID-19 are eased state by state

Monday, April 20, 2020 - Thousand of individuals have filed suit claiming Johnson's Baby Powder caused them to develop cancer and they are now concerned about the delays they may face in having their case heard. Despite the state-by-state shutdowns cases involving Johnson & Johnson are going forward regardless of the COVID-19 health risks. According to Med Truth.com an appeal of a $4 billion jury award to plaintiffs that alleged Johnson's Baby Powder caused their ovarian cancer, that was slated to begin but delayed has been rescheduled for April 24, 2020, started by a Missouri appellate court. Interestingly the number of attorneys on both sides of the argument will be limited to two and the trial will be live-streamed on social media and videotaped instead of allowing a live audience. According to MT: "Arguments will b live-streamed on the court's Facebook page and a recorded version will be uploaded on YouTube. Each side will have 30 minutes to present their principal argument and Johnson & Johnson will receive six additional minutes for rebuttal." Talcum powder lawyer offers a no obligation and free consultation if you or a loved one have been harmed from talcum powder cancer.

The issue being addressed is whether or not to overturn a massive $550 million compensatory damage and $4.14 billion in punitive damage amount awarded last year to 22 plaintiffs that argued Johnson's Baby Powder caused 22 women's ovarian cancer. A central issue court must address when considering delaying personal injury trials and appeals are that the illnesses the plaintiffs suffer could cause them to die during lengthy delays. Several states including California have special statutes that allow terminally ill or elderly plaintiffs to have their cases moved to the front of the list. Most if not all of the 16,000 plaintiffs suing Johnson & Johnson for cancer their iconic talcum powder allegedly caused has terminal ovarian cancer or non-Hodgkins lymphoma and others have terminal mesothelioma cancer of the lining of the lungs. According to the court record, several plaintiffs have died while waiting for their turn in court and judges are weighing these facts when deciding to open the courts back up. Med Truth quoted plaintiff attorney Mark Lanier as telling the website: "The court has made a measured and responsible decision weighing the seriousness of [COVID]-19 with the truth that several plaintiffs have already died post-trial, and those still alive are entitled to a just review of their cases." The case being held next week could set the example for limiting attendance for trials going forward.

Since the case was decided last year a new study has been published that claims that there is no discernible connection statistically speaking between using talcum powder on the genital region and women developing ovarian cancer. According to NPR.com, a study by a questionnaire of over one quarter of one million women conducted by the National Institute of Environmental Health Sciences and the National Cancer Institute determined that the increase of ovarian cancer for women who used talcum powder regularly was not enough to connect the two. According to NPR: "... women who had ever used powder had an 8% increased risk of ovarian cancer compared to those who never used it. That is not a statistically significant increase. Ovarian cancer is very rare and the lifetime risk of getting it is 1.3% so an increase of 8% to that is small."

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.